Ultragenyx Pharmaceutical reported $70K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Aptinyx Inc APTX:US $ 677K 0
Biocryst Pharmaceuticals BCRX:US $ 1.86M 0.01M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.71M 0M
Epizyme EPZM:US $ 0.02M 0.01M
Esperion Therapeutics ESPR:US $ 61K 0
Insmed INSM:US $ 1.19M 6K
Karyopharm Therapeutics KPTI:US $ 8K 0
Kyowa Hakko Kirin 4151:JP Y 26745M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 86K 1000